The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of Hetronifly ...

The US Food and Drug Administration (FDA) has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active ...

British biotech Vicebio has secured $100 million in a series B funding round to advance its next-generation vaccines against ...

Teva Pharmaceuticals has announced positive results from its Phase III SOLARIS trial of TEV-749, a long-acting injectable ...

French ophthalmics company Nicox announced that its exclusive Chinese partner, Ocumension Therapeutics, has received approval ...

The Health Sciences Authority (HSA) of Singapore has approved Merck & Co’s Winrevair (sotatercept), for the treatment of ...

Shanghai-based Fosun Pharmaceutical has acquired the remaining 50% stake in Fosun Kite Biotechnology from Kite Pharma for $27 ...

On Friday, the USA’s Federal Trade Commission (FTC) brought action against the three largest prescription drug benefit ...

The US Food and Drug Administration (FDA) has approved Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) as a first line treatment option for adult patients ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...

The European Commission has conditionally approved the marketing application submitted by Ipsen for Iqirvo (elafibranor) 80mg ...